William Conkling Net Worth

Mr. William Conkling biography

William Conkling is the Chief Exec. Officer at Rafael Inc.

What is the salary of Mr Conkling?

As the Chief Exec. Officer of Rafael Inc, the total compensation of Mr Conkling at Rafael Inc is $382,500. There are 1 executives at Rafael Inc getting paid more, with Menachem Ash having the highest compensation of $1,489,880.

How old is Mr Conkling?

Mr Conkling is 49, he's been the Chief Exec. Officer of Rafael Inc since . There are 8 older and 1 younger executives at Rafael Inc. The oldest executive at Rafael Holdings Inc is Stephen Greenberg, 75, who is the Lead Independent Director.

What's Mr Conkling's mailing address?

William's mailing address filed with the SEC is C/O CYCLO THERAPEUTICS, INC., 6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL, 32653.

Insiders trading at Rafael Inc

Over the last 7 years, insiders at Rafael Inc have traded over $423,229 worth of Rafael Inc stock and bought 3,338,367 units worth $11,056,239 . The most active insiders traders include Howard S Jonas, Mark Anthony Mc Camish et Plus, Llc I9. On average, Rafael Inc executives and independent directors trade stock every 87 days with the average trade being worth of $1,371,943. The most recent stock trade was executed by Howard S Jonas on 5 August 2022, trading 112,561 units of RFL stock currently worth $211,615.

What does Rafael Inc do?

we are a wholly owned subsidiary of rafael holdings focused on pipeline development

Rafael Inc executives and stock owners

Rafael Inc executives and other stock owners filed with the SEC include:

• Menachem Ash,
  President, General Counsel
• William Conkling,
  Chief Exec. Officer
• David Polinsky,
  Chief Financial Officer
• Howard S. Jonas,
  Founder & Chairman
• David A. Polinsky Esq.,
  Chief of Staff
• Howard Jonas,
  Chairman of the Board, Chief Executive Officer
• Michael Weiss,
  Independent Director
• Boris Pasche,
  Independent Director
• Stephen Greenberg,
  Lead Independent Director
• Joyce J. Mason Esq.,
  Corp. Sec.
• Dr. Rick Ewing,
  Head of Drug Discovery
• Gus Kodersha,
  Chief Technical Operations Officer
• Barbara A. Ryan,
  Investor Relations Officer
• Patrick Fabbio M.B.A.,
  CFO & Pres
• Mary Margaret Huizinga,
  Chief Devel. & Medical Officer
• John Goldberg,
  CHIEF MEDICAL OFFICER
• William Conkling,
  Chief Executive Officer
• Corp Idt,
  10% owner
• Joyce J Mason,
  
• Ashok D Marin,
  Chief Legal Officer
• Mark Anthony Mc Camish,
  Director
• Shannon Thyme Klinger,
  Director
• Patrick Fabbio,
  CFO & President
• Ameet Mallik,
  Director
• Plus, Llc I9,
  10% owner